MDT - MannKind's Technosphere Platform Issues Are Worth Discussing
The major point for this article is to discuss the conflicting information that MannKind has issued in recent public events, information that is in direct conflict with information shared on every Afrezza prescription that is filled for a patient. The nature of this conflict is critical information for the prescribing medical professionals and most assuredly important for their patients. The title of my article can be resolved only by MannKind clarifying which of their claims represent the factual data points at issue.
Al Mann was a very creative visionary where he developed MannKind (MNKD